Skip to main content
logo
OKYO Pharma Limited (OKYO)
NASDAQ: OKYO · Real-Time Price · USD
1.385
+0.005 (0.36%)
At close: Sep 25, 2026, 4:00 PM EDT
1.380
-0.005 (-0.36%)
After-hours: Sep 25, 2026, 7:30 PM EDT

OKYO Pharma Cash Flow Statement

Millions USD. Fiscal year is Apr - Mar.

Operating Activities

Fiscal Quarter
Q4 2026Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Period Ending
Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23
Net Income
-8.95-6.78-4.61-4.66-4.71-7.7-10.69-13.76-16.83-16.71
Depreciation & Amortization
0000000000
Stock-Based Compensation
1.611.481.361.391.411.281.151.141.131.18
Other Operating Activities
2.042.222.41.13-0.151.42.963.243.531.85
Change in Accounts Receivable
-0.010.020.01--0.3-0.6-0.3-0.13
Change in Accounts Payable
-0.64-1.05-1.470.131.722.673.612.922.233.11
Change in Other Net Operating Assets
0.01-0.4-0.8-0.45-0.090.270.630.530.440.21
Operating Cash Flow
-5.94-4.52-3.1-2.45-1.81-2.37-2.94-6.21-9.49-10.24
Operating Cash Flow Growth (YoY)
----------

Investing Activities

Fiscal Quarter
Q4 2026Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Period Ending
Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23
Capital Expenditures
-0.01-0-0-0-0-0----0
Investment in Securities
-6-3--------
Investing Cash Flow
-6.01-3-0-0-0-0----0

Financing Activities

Fiscal Quarter
Q4 2026Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Period Ending
Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23
Long-Term Debt Issued
----0.95-----
Total Debt Issued
-0.470.950.950.950.4800-1
Net Debt Issued (Repaid)
-0.470.950.950.950.4800-1
Issuance of Common Stock
25.0215.255.473.591.712.232.764.486.217.56
Other Financing Activities
---------0.31
Financing Cash Flow
25.0215.726.424.542.662.712.764.486.218.87

Net Cash Flow

Fiscal Quarter
Q4 2026Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Period Ending
Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23
Foreign Exchange Rate Adjustments
-0.05-0.07-0.09-0.1-0.11-0.28-0.45-0.190.060.08
Net Cash Flow
13.038.133.231.980.730.05-0.63-1.92-3.22-1.29

Free Cash Flow

Fiscal Quarter
Q4 2026Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Period Ending
Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23
Free Cash Flow
-5.94-4.52-3.1-2.46-1.81-2.38-2.94-6.21-9.49-10.24
Free Cash Flow Growth (YoY)
----------
Free Cash Flow Per Share
-0.16-0.12-0.07-0.06-0.05-0.07-0.09-0.20-0.32-0.38
Levered Free Cash Flow
-2.1-1.6-3-3.44-2.72-2.66---3.09-4.65
Unlevered Free Cash Flow
-1.81-1.39-2.88-3.11-2.18-1.82---2.44-4.29
Free Cash Flow After Leases
-5.94-4.52-3.1-2.46-1.81-2.38-2.94-6.21-9.49-10.24

Additional Metrics

Fiscal Quarter
Q4 2026Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Period Ending
Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23
Cash Income Tax Paid
-1.95----2-----
Change in Working Capital
-0.63-1.44-2.25-0.311.632.633.643.162.673.44
SEC Filings: 10-K · 10-Q